Catherine Havlik Coste Insider Profile
4 Followers
Catherine Havlik Coste, Director at Renalytix, holds 1.62M shares in Renalytix (Ticker: RENXF). Most recently, Catherine Havlik Coste Bought 1,231,102 shares of Renalytix on Sep 03, 2026 for an estimated value of $73.87K.
Catherine Havlik Coste's Trading History
| RENXFRenalytix | Sep 03, 2026 | Director | Informative Buy | 73.87K | $98.59K | |||||||||||||||||||||||||||||
RENXF Insider Shares: 1.62M (26.77%)
| ||||||||||||||||||||||||||||||||||
You May Also Like
Catherine Havlik Coste insider profile FAQ
What is the percentage of profitable transactions made by Catherine Havlik Coste?
The percentage of profitable transactions made by Catherine Havlik Coste is 33%.
What is the average return per transaction made by Catherine Havlik Coste?
The average return per transaction made by Catherine Havlik Coste is -9.00%.
What stocks does Catherine Havlik Coste hold?
Catherine Havlik Coste holds: RENXF stocks.
What was Catherine Havlik Coste’s latest transaction?
Catherine Havlik Coste’s latest transaction was an Informative Buy of $73.87K.
What was Catherine Havlik Coste's most profitable transaction?
Catherine Havlik Coste’s most profitable transaction was an Informative Buy of RENXF stock on October 1, 2024. The return on the trade was 11.20%.
What is Catherine Havlik Coste's role in Renalytix?
Catherine Havlik Coste's role in Renalytix is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.